NUS develop AI platform to identify personalized drug combinations for myeloma patients

(National University of Singapore) A multidisciplinary team of researchers from the National University of Singapore has developed an artificial intelligence technology platform that could potentially change the way drug combinations are being designed, hence enabling doctors to determine the most effective drug combination for a patient quickly.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news